| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| Gene symbol | MUC1 | Synonyms | ADMCKD, ADMCKD1, ADTKD2, CA 15-3, CD227, Ca15-3, EMA, H23AG, KL-6, MAM6, MCD, MCKD, MCKD1, MUC-1, MUC-1/SEC, MUC-1/X, MUC1/ZD, PEM, PEMT, PUM | Type of gene | protein-coding |
| Chromosome | 1 | Map location | 1q22 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | mucin 1, cell surface associated | ||||
| GTO ID | GTC0796 |
| Trial ID | ChiCTR1900022609 |
| Disease | Lung Cancer |
| Altered gene | MUC1|CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19/MUC-1 CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Not Recruiting |
| Title | (MUC-1 + CD19) targeted Chimeric Antigen Receptor T Cells (CART) Therapy in lung cancer |
| Year | 2019 |
| Country | China |
| Company sponsor | The Fifth Hospital Affiliated to Zhongshan University |
| Cohort 1 | |||||||
|
|||||||